Dr. David Schneider's lab at NYU studies how the brain processes sounds we make ourselves, particularly in skills like speaking and making music. By using mice as model organisms, his team investigates how neural networks in the auditory cortex respond to sound and how they help us learn and correct our behaviors based on what we hear. This research enhances our understanding of the brain circuits involved in learning through auditory feedback.

Dr. Jayeeta Basu's lab at NYU School of Medicine focuses on understanding the brain circuits involved in memory and how they are affected by Alzheimer's disease (AD). By studying specific types of inhibitory neurons in the hippocampus and entorhinal cortex, the lab aims to identify new therapeutic targets to improve memory function in patients suffering from early stages of AD. The research combines advanced techniques in neuroscience, including imaging and electrophysiology, to explore the resilience and vulnerability of these circuits in both animal models and human brain samples.

Dr. Leigh Charvet's lab focuses on developing innovative treatments for cannabis addiction, particularly using a combination of transcranial direct current stimulation (tDCS) and mindfulness techniques. Their research aims to create an accessible home-based intervention that utilizes telehealth technology to help people recover from cannabis use disorder (CUD). By conducting clinical trials, the lab seeks to validate the efficacy of their approach and refine methods to ensure safety and effectiveness for participants.

Dr. Simon Henin's lab at NYU focuses on understanding how our brains learn from experiences using statistical learning, a key process in acquiring language and other cognitive skills. By combining advanced imaging techniques with direct recordings from the brains of patients, the lab aims to reveal how different regions of the brain, particularly the cortex and hippocampus, interact while we learn. This research could lead to new insights and therapies for cognitive deficits associated with neurological disorders.

Dr. Thomas M. Wisniewski's lab at NYU studies the cognitive impacts of COVID-19 on older adults, especially those who may develop Alzheimer's disease or related dementias. They focus on identifying biomarkers in the blood that could predict cognitive decline following COVID-19 infection. By examining patients over time, the lab aims to understand how COVID-19 affects brain health and what factors contribute to cognitive impairment in this population.

Dr. Christine Constantinople's lab at NYU focuses on understanding how specific brain circuits, especially those involving dopamine and acetylcholine, influence learning and decision-making in changing environments. By studying rats, her research explores dynamic learning processes and how different neuromodulators can dictate whether the brain focuses on learning or movement. The lab employs advanced techniques like optogenetics and electrophysiology to manipulate and observe neural activity during learning tasks, aiming to uncover new therapeutic targets for neuropsychiatric disorders.

Dr. Adeen Flinker's research lab focuses on understanding how our brains process speech by analyzing the way sound is integrated over time in the auditory cortex. They use advanced techniques to study patients who have had neurosurgery, allowing them to capture detailed brain activity as individuals listen to speech. The goal is to uncover how we recognize words and sentences and to develop new treatments for speech disorders.

Dr. Andre Antonio Fenton's lab at NYU focuses on understanding how memories are formed and stored in the brain, particularly through the study of synaptic plasticity in the hippocampus. The research examines the mechanisms behind long-term memory, testing established theories on synaptic changes that occur during the learning process. By using techniques like optogenetics, the lab aims to investigate how specific neurons contribute to memory storage and what happens when these processes are disrupted.

Dr. Roozbeh Kiani's lab at New York University focuses on understanding and controlling neural activity in the brain to develop new treatments for disorders like Parkinson's disease and depression. They employ advanced techniques to monitor and influence brain circuits during decision-making and movement, bridging the gap between cognitive functions and motor actions. By using data-driven methods and targeted stimulation, their research aims to advance therapies and brain-computer interface technologies, providing solutions for neurological and psychiatric conditions.

Dr. Cristina Alberini's lab focuses on understanding how memories are formed and maintained at the molecular level. They study the role of certain genes, particularly insulin-like growth factor 2 (IGF-2), in strengthening long-term memories. By exploring the mechanisms of memory consolidation, the lab aims to develop strategies to treat cognitive impairments associated with disorders like autism and Alzheimer's disease.

Dr. Eric Klann's lab at New York University focuses on understanding how protein synthesis affects memory and language in brain disorders. By studying specific brain regions in mice, they aim to uncover the processes behind memory storage, retrieval, and loss. They are also investigating how abnormalities in protein translation contribute to diseases like Alzheimer's and fragile X syndrome, with hopes of finding new treatment targets.

Dr. Anli A Liu's research lab at NYU School of Medicine focuses on understanding how the brain organizes and recalls memories, particularly through the interactions between the hippocampus and the neocortex. By studying brain activity in epilepsy patients while they watch films and engage in visual exploration, the lab aims to uncover how memories are formed and segmented into distinct events. This research has important implications for improving diagnosis and treatment of memory disorders.

Un Jung Kang's research lab focuses on understanding multiple system atrophy (MSA), a rare and fatal neurodegenerative disease. The lab uses advanced single nucleus RNA sequencing techniques to investigate how different brain cells are affected by MSA. By analyzing gene expression changes in postmortem brain tissue from MSA patients, the lab aims to uncover mechanisms leading to neuronal death and explore potential therapeutic targets.

Dmitry Rinberg's lab at NYU focuses on understanding how the brain processes smells and how this ability can be harnessed for medical diagnostics. They investigate the neural mechanisms involved in odor perception and how specific smells can indicate various health conditions. Using advanced imaging techniques, the lab aims to explore the connections between nerve cells in the olfactory system and how these contribute to disease detection. By doing so, they hope to uncover fundamental principles of olfaction while also paving the way for innovative diagnostic tools.

Dr. Giuseppina Pilloni's research lab at NYU focuses on innovating noninvasive brain stimulation techniques, specifically transcranial direct current stimulation (tDCS), to improve treatment for neuropsychiatric symptoms like depression. The lab aims to integrate heart rate variability (HRV) as a biomarker to tailor tDCS therapies, making them more personalized and effective. By utilizing telehealth technologies, they seek to enhance accessibility and scalability of mental health interventions.

Dr. Giulietta Maria Riboldi's lab at NYU is focused on understanding Early Onset Parkinson's Disease (EOPD), which occurs before the age of 50. The lab studies how genetic factors, inflammatory responses, and alpha-synuclein protein accumulation contribute to different subtypes of EOPD. By analyzing patient data and biological samples, the lab works to identify distinct disease mechanisms that could lead to better-tailored treatments and improved patient care.

Dr. James Salzer's lab at NYU focuses on understanding how Schwann cells, which support and insulate nerve fibers, influence the health and function of axons. By studying genetically modified mice, the lab investigates how defects in Schwann cells lead to neurodegenerative diseases, particularly focusing on the mechanisms behind conditions like Charcot-Marie-Tooth disease. The research has the potential to reveal new treatment approaches for peripheral nerve disorders that result from Schwann cell dysfunction.

Dr. Jeremy S. Dasen's lab at New York University School of Medicine studies how neurons in the spinal cord assemble the networks necessary for controlling movement. They focus on understanding the genetic factors that shape these neurons during development, particularly the role of Hox transcription factors in creating different types of motor neurons. The lab aims to uncover the molecular mechanisms behind motor circuit formation, which could lead to therapies for spinal cord injuries and diseases.

Dr. Claude Steriade's research lab at NYU School of Medicine focuses on advancing the diagnosis and treatment of autoimmune epilepsy. By using innovative imaging techniques like TSPO-PET and MRI, the lab aims to uncover the underlying neuroinflammatory processes that contribute to the condition. The ultimate goal is to develop more effective diagnostic markers and treatment strategies for patients suffering from this complex disorder.

Dr. Henrieta Scholtzova's lab at NYU School of Medicine is focused on understanding how the immune system can be harnessed to tackle Alzheimer's disease, particularly through a unique approach using the TLR9 pathway. The lab uses squirrel monkeys, which develop age-related amyloid conditions similar to humans, to test new therapies aimed at improving cognitive function and preventing complications that often arise with current treatments. By integrating various biomarker data and advanced imaging techniques, they aim to better understand and treat cerebral amyloid angiopathy, a common risk factor for cognitive decline in Alzheimer's patients.